Maintaining or breaking CD8+ T-cell tolerance to β islet cell antigens: Lessons from transgenic mouse models

Journal of Autoimmunity

Volumn 22, Issue 2, 2004, Pages 115-120

  Piaggio, Eliane ^a,b   Hartemann Heurtier, Agnès ^b   Cabarrocas, Julie ^a,b   Desbois, Sabine ^a,b   Mars, Lennart T ^a,b   Zappulla, Jacques P ^a,b   Liblau, Roland S ^a,b,c  

^a CHU PURPAN   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CHU RANGUEIL   (France)

Author keywords

Autoimmunity; CD8+ T cells; Diabetes; Tolerance; Transgenic mice

Indexed keywords

AUTOANTIGEN; CD8 ANTIGEN; CELL ANTIGEN;

CROSS TOLERANCE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; ONTOGENY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

EID: 1342308434     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2003.10.004     Document Type: Article

References (46)

1. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
2. Oldstone M.B., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:1991;319-331.
3. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med. 184:1996;923-930.
4. Lo D., Freedman J., Hesse S., Palmiter R.D., Brinster R.L., Sherman L.A. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol. 22:1992;1013-1022.
5. Morgan D.J., Kreuwel H.T., Sherman L.A. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol. 163:1999;723-727.
6. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med. 186:1997;239-245.
7. Heath W.R., Kurts C., Miller J.F., Carbone F.R. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med. 187:1998;1549-1553.
8. Heath W.R., Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol. 1:2001;126-134.
9. Kurts C., Sutherland R.M., Davey G., Li M., Lew A.M., Blanas E., et al. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A. 96:1999;12703-12707.
10. Miller J.F., Kurts C., Allison J., Kosaka H., Carbone F., Heath W.R. Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens. Immunol Rev. 165:1998;267-277.
11. Kurts C., Miller J.F., Subramaniam R.M., Carbone F.R., Heath W.R. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med. 188:1998;409-414.
12. Hugues S., Mougneau E., Ferlin W., Jeske D., Hofman P., Homann D., et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity. 16:2002;169-181.
13. Kreuwel H.T., Aung S., Silao C., Sherman L.A. Memory CD8(+) T cells undergo peripheral tolerance. Immunity. 1:2002;73-81.
14. Morgan D.J., Kurts C., Kreuwel H.T., Holst K.L., Heath W.R., Sherman L.A. Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A. 96:1999;3854-3858.
15. Hoglund P., Mintern J., Waltzinger C., Heath W., Benoist C., Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med. 189:1999;331-339.
16. Mintern J.D., Sutherland R.M., Lew A.M., Shortman K., Carbone F.R., Heath W.R. Constitutive, but not inflammatory, cross-presentation is disabled in the pancreas of young mice. Eur J Immunol. 32:2002;1044-1051.
17. Hernandez J., Aung S., Redmond W.L., Sherman L.A. Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med. 94:2001;707-717.
18. Davey G.M., Kurts C., Miller J.F., Bouillet P., Strasser A., Brooks A.G., et al. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med. 196:2002;947-955.
19. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med. 196:2002;1099-1104.
20. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med. 192:2000;1685-1696.
21. Vizler C., Bercovici N., Heurtier A., Pardigon N., Goude K., Bailly K., et al. Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts. J Immunol. 165:2000;6314-6321.
22. Morgan D.J., Liblau R., Scott B., Fleck S., McDevitt H.O., Sarvetnick N., et al. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol. 157:1996;978-983.
23. Vizler C., Bercovici N., Cornet A., Cambouris C., Liblau R.S. Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models. Immunol Rev. 169:1999;81-92.
24. Pardigon N., Bercovici N., Calbo S., Santos-Lima E.C., Liblau R., Kourilsky P., et al. Role of co-stimulation in CD8+ T cell activation. Int Immunol. 10:1998;619-630.
25. Kurts C., Carbone F.R., Barnden M., Blanas E., Allison J., Heath W.R., et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med. 86:1997;2057-2062.
26. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:1998;480-483.
27. Yang Y., Wilson J.M. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science. 273:1996;1862-1864.
28. Shu U., Kiniwa M., Wu C.Y., Maliszewski C., Vezzio N., Hakimi J., et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol. 25:1995;1125-1128.
29. Hernandez J., Aung S., Marquardt K., Sherman L.A. Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med. 196:2002;323-333.
30. Bennett S.R., Carbone F.R., Karamalis F., Miller J.F., Heath W.R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med. 186:1997;65-70.
31. Green E.A., Flavell R.A. The temporal importance of TNFalpha expression in the development of diabetes. Immunity. 12:2000;459-469.
32. Green E.A., Choi Y., Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity. 16:2002;183-191.
33. Vezys V., Lefrancois L. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol. 169:2002;6677-6680.
34. Gottlieb P.A., Eisenbarth G.S. Insulin-specific tolerance in diabetes. Clin Immunol. 102:2002;2-11.
35. Liblau R., Tisch R., Bercovici N., McDevitt H.O. Systemicantigen in the treatment of T-cell-mediated autoimmune diseases. Immunol Today. 18:1997;599-604.
36. Kyburz D., Aichele P., Speiser D.E., Hengartner H., Zinkernagel R.M., Pircher H. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol. 23:1993;1956-1962.
37. Aichele P., Kyburz D., Ohashi P.S., Odermatt B., Zinkernagel R.M., Hengartner H., et al. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc Natl Acad Sci U S A. 91:1994;444-448.
38. von Herrath M.G., Coon B., Lewicki H., Mazarguil H., Gairin J.E., Oldstone M.B. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Immunol. 161:1998;5087-5096.
39. Bercovici N., Heurtier A., Vizler C., Pardigon N., Cambouris C., Desreumaux P., et al. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage. J Immunol. 165:2000;202-210.
40. Liblau R.S., Wong F.S., Mars L.T., Santamaria P. Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity. 17:2002;1-6.
41. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 16:1995;34-38.
42. Shevach E.M. Regulatory T cells in autoimmmunity. Annu Rev Immunol. 18:2000;423-449.
43. Lin C.Y., Graca L., Cobbold S.P., Waldmann H. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol. 3:2002;1208-1213.
44. van Maurik A., Herber M., Wood K.J., Jones N.D. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol. 169:2002;5401-5404.
45. Kursar M., Bonhagen K., Fensterle J., Kohler A., Hurwitz R., Kamradt T., et al. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med. 196:2002;1585-1592.
46. Hewitierz A, Mars L, Bercovici N, Desbois S, Cambowis C, Piaggio E et al. An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes. J. Immunol in press.